Editas Medicine to Present at Investor Conferences in March

CAMBRIDGE, Mass., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT), a leading genome editing company, today announced that management will participate in two upcoming investor conferences in March.  Details of the presentations are as follows:

Live webcasts of the presentations will be available on the Investors & Media section of the Editas website at www.editasmedicine.com.  Archived replays will be available for approximately 30 days following the respective presentations.

About Editas MedicineEditas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes.  The company was founded by world leaders in genome editing, and its mission is to translate the promise of genome editing science into a broad class of transformative genomic medicines to benefit the greatest number of patients.

Media Contact
Dan Budwick

Pure Communications, Inc.

(973) 271-6085
[email protected]

Investor Contact
Mark Mullikin
Editas Medicine, Inc.
(617) 401-9083
[email protected]

You May Also Be Interested In

• Hozpitality Celebrates California's Top 30 General Managers at Inaugural Hozpitality's Best GM Powerlist 2026
• ChowChow Cloud International Holdings Limited Provides Response to Unusual Market Action
• Women Leaders Association Adds Lisa Reilly as Boston Coaching Partner, Bringing 23 Years of Biotech Leadership and Her Reclamation Method to High-Achieving Women